Hanspeter Gerber

Company: Codeable Therapeutics

Job title: Chief Scientific Officer

Seminars:

pHLAs as Novel Targets & Therapeutic Index Guided ADC Development 12:00 pm

pHLAs: an emerging class of ADC targets Therapeutic Index based stage gate decisions to guide ADC development Immunogenic cell death of payloads to increase DOR and PFS of ADCsRead more

day: Day Two

Panel Discussion – Thinking Strategically About What Targets You Select 3:30 pm

Understanding where your target choice and ADC fits into the ADC and wider oncology landscape? How do you differentiate yourself through using improved linker-payload technologies on previously validated targets? Balancing risk in your pipeline through your target choice Novel targets or previously validated targets? Discussing the role of future HER2 ADCsRead more

day: Day One